| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 565,808 | 1,276,710 | 777,504 | 853,069 | | Cost of Revenue | 97,334 | 117,526 | 137,232 | 173,523 | | | Gross Profit |
-
| 1,159,184 | 640,272 | 679,546 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (233,976) | 412,391 | 369,319 | 390,625 | | Non Recurring | (97,526) | 41,969 | 716,665 | 242,563 | | Others | 361,413 | 781,433 | 504,901 | 614,131 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (76,609) | (950,613) | (567,773) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (195,429) | (76,609) | (950,613) | (567,773) | | Interest Expense | 58,418 | 26,482 | 27,695 | 43,235 | | Income Before Tax | (253,847) | (103,091) | (978,308) | (611,008) | | Income Tax Expense | (98,565) | (34,239) | (151,727) | (126,512) | | Minority Interest |
-
|
-
|
-
| 1,520 | | | | Net Income From Continuing Ops | (151,139) | (68,852) | (826,581) | (482,976) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (151,139) | (68,852) | (826,581) | (482,976) | | Preferred Stock And Other Adjustments | (28,352) | 28,180 | (25,746) | (15,108) | | | Net Income Applicable To Common Shares | ($179,491) | ($40,672) | ($852,327) | ($498,084) |
|
0.02% Nasdaq 
0.48%
Income Statement
